Oklahoma 2024 Regular Session

Oklahoma Senate Bill SB116 Compare Versions

Version 1 (Old)

Version 2 (New)

Old	New		Differences
1	1
2	2
3		-	ENGR. S. B. NO. 116 Page 1 1
	3	+	SENATE FLOOR VERSION – SB116 SFLR Page 1
	4	+	(Bold face denotes Committee Amendments) 1
4	5		2
5	6		3
6	7		4
7	8		5
8	9		6
9	10		7
10	11		8
11	12		9
12	13		10
13	14		11
14	15		12
15	16		13
16	17		14
17	18		15
18	19		16
19	20		17
20	21		18
21	22		19
22	23		20
23	24		21
24	25		22
25	26		23
26	27		24
27	28
28		-	ENGROSSED SENATE
29		-	BILL NO. 116 By: Bullard and Burns of the
30		-	Senate
	29	+	SENATE FLOOR VERSION
	30	+	February 8, 2023
31	31
32		-	and
33	32
34		-	Williams of the House
	33	+	SENATE BILL NO. 116 By: Bullard
	34	+
	35	+
35	36
36	37
37	38
38	39		An Act relating to medical marijuana; amending 63
39	40		O.S. 2021, Section 425, as last amended by Section 2,
40	41		Chapter 317, O.S.L. 2022 (63 O.S. Supp. 2022, Section
41	42		425), which relates to discrimination against medical
42	43		marijuana license holder; prohibiting certain medical
43	44		marijuana facilities from operating in certain areas;
44	45		amending 63 O.S. 2021, Section 427.2, as last amended
45	46		by Section 1, Chapter 317, O.S.L. 2022 (63 O.S. Supp .
46	47		2022, Section 427.2), which relates to definitions;
47	48		adding definition; updating statutory languag e; and
48	49		providing an effective date .
49	50
50	51
51	52
52	53
53	54
54	55		BE IT ENACTED BY THE PEOPLE OF THE STATE OF OKLAHOMA:
55	56		SECTION 1. AMENDATORY 63 O.S . 2021, Section 425, as last
56	57		amended by Section 2, Chapter 317, O.S.L. 2022 (63 O.S. Supp. 2022,
57	58		Section 425), is amended to read as follows:
58	59		Section 425. A. No school or landlord may refuse to enr oll or
59	60		lease to and may not otherwise penalize a person s olely for his or
60	61		her status as a medical marijuana patient licensee, unless failing
61	62		to do so would cause the school or landlord the potential to lose a
62	63		monetary or licensing-related benefit under fed eral law or
63	64		regulations.
64	65
65		-	ENGR. S. B. NO. 116 Page 2 1
	66	+	SENATE FLOOR VERSION – SB116 SFLR Page 2
	67	+	(Bold face denotes Committee Amendments) 1
66	68		2
67	69		3
68	70		4
69	71		5
70	72		6
71	73		7
72	74		8
73	75		9
74	76		10
75	77		11
76	78		12
77	79		13
78	80		14
79	81		15
80	82		16
81	83		17
82	84		18
83	85		19
84	86		20
85	87		21
86	88		22
87	89		23
88	90		24
89	91
90	92		B. Unless a failure to do so wo uld cause an employer the
91	93		potential to lose a monetary or licensing -related benefit under
92	94		federal law or regulations, an employer may not discriminate against
93	95		a person in hiring, termination or impos ing any term or condition of
94	96		employment or otherwise pena lize a person based upon the status of
95	97		the person as a medical marijuana patient licensee. Employers may
96	98		take action against a medical marijuana patient licensee if the
97	99		licensee uses or possesses ma rijuana while in his or her place of
98	100		employment or during the hours of employment. Employers may not
99	101		take action against a medical marijuana patient licensee solely
100	102		based upon the status of an employee as a medical mari juana patient
101	103		licensee or the result s of a drug test showing positive for
102	104		marijuana or its components.
103	105		C. For the purposes of medical care, including organ
104	106		transplants, the authorized use of marijuana by a medical marijuana
105	107		patient licensee shall be consi dered the equivalent of the use of
106	108		any other medication under the direction of a physician an d does not
107	109		constitute the use of an illicit substance or otherwise disqualify a
108	110		registered qualifying patient from medical care.
109	111		D. No medical marijuana patient l icensee may be denied custody
110	112		of or visitation or parenting t ime with a minor child, and ther e is
111	113		no presumption of neglect or child endangerment for conduct allowed
112	114		under this law unless the behavior of the medical mariju ana patient
113	115
114		-	ENGR. S. B. NO. 116 Page 3 1
	116	+	SENATE FLOOR VERSION – SB116 SFLR Page 3
	117	+	(Bold face denotes Committee Amendments) 1
115	118		2
116	119		3
117	120		4
118	121		5
119	122		6
120	123		7
121	124		8
122	125		9
123	126		10
124	127		11
125	128		12
126	129		13
127	130		14
128	131		15
129	132		16
130	133		17
131	134		18
132	135		19
133	136		20
134	137		21
135	138		22
136	139		23
137	140		24
138	141
139	142		licensee creates an un reasonable danger to the safety of t he minor
140	143		child.
141	144		E. No person who possesses a medical mar ijuana patient license
142	145		may be unduly withheld from holding another state -issued license by
143	146		virtue of his or her status as a medi cal marijuana patient licensee
144	147		including, but not limited to, a conceal ed carry permit.
145	148		F. 1. No city or local municipality ma y unduly change or
146	149		restrict zoning laws to prevent the opening of a medical marijuana
147	150		dispensary.
148	151		2. For purposes of this sub section, an undue change or
149	152		restriction of municipal zoning laws means an act which entirely
150	153		prevents medical marijuana dispensari es from operating within
151	154		municipal boundaries as a matter of law. Municipalities may follow
152	155		their standard planning and zonin g procedures to determine if
153	156		certain zones or districts would be appropri ate for locating
154	157		marijuana-licensed premises, medical mar ijuana businesses or any
155	158		other premises where marijuana or its by -products are cultivated,
156	159		grown, processed, stored or manufac tured.
157	160		3. A medical marijuana dispen sary does not include those other
158	161		entities licensed by the Ok lahoma Medical Marijuana Authori ty as
159	162		marijuana-licensed premises, medical marijuana businesses or other
160	163		facilities or locations where marijuana or any produ ct containing
161	164		marijuana or its by-products are cultivated, grown, processe d,
162	165		stored or manufactured .
163	166
164		-	ENGR. S. B. NO. 116 Page 4 1
	167	+	SENATE FLOOR VERSION – SB116 SFLR Page 4
	168	+	(Bold face denotes Committee Amendments) 1
165	169		2
166	170		3
167	171		4
168	172		5
169	173		6
170	174		7
171	175		8
172	176		9
173	177		10
174	178		11
175	179		12
176	180		13
177	181		14
178	182		15
179	183		16
180	184		17
181	185		18
182	186		19
183	187		20
184	188		21
185	189		22
186	190		23
187	191		24
188	192
189	193		G. 1. The location of any me dical marijuana dispensary is
190	194		specifically prohibited within one thousand (1,000) feet of any
191	195		public school or private school . The distance indicated in this
192	196		paragraph shall be measured from the nea rest property line of suc h
193	197		public school or private schoo l to the nearest perimeter wall of the
194	198		licensed premises of such medical marijuana dispensary. If a
195	199		medical marijuana dispen sary met the requirements of this para graph
196	200		at the time of its initial lic ensure, the medical marij uana
197	201		dispensary licensee shall b e permitted to continue operating at the
198	202		licensed premises in the same manner and not be subject to
199	203		nonrenewal or revocation due to subsequent events or changes in
200	204		regulations occurring after licensu re that would render the medical
201	205		marijuana dispensary in violation by being within one thousand
202	206		(1,000) feet of a public school or private school. If any public
203	207		school or private sc hool is established within one thousan d (1,000)
204	208		feet of any medical mariju ana dispensary after such medical
205	209		marijuana dispensary ha s been licensed, the provisions of this
206	210		paragraph shall not be a deterrent to the renewal of such license or
207	211		warrant revocation of the license. For purposes of th is paragraph,
208	212		a property owned, used or operated by a public school or by a
209	213		private school that is not used for classroom instruction on core
210	214		curriculum, such as an administrative building, athletic facility,
211	215		ballpark, field or stadium, shall not constitut e a public school or
212	216
213		-	ENGR. S. B. NO. 116 Page 5 1
	217	+	SENATE FLOOR VERSION – SB116 SFLR Page 5
	218	+	(Bold face denotes Committee Amendments) 1
214	219		2
215	220		3
216	221		4
217	222		5
218	223		6
219	224		7
220	225		8
221	226		9
222	227		10
223	228		11
224	229		12
225	230		13
226	231		14
227	232		15
228	233		16
229	234		17
230	235		18
231	236		19
232	237		20
233	238		21
234	239		22
235	240		23
236	241		24
237	242
238	243		private school unless such property is l ocated on the same campus as
239	244		a building used for classroom instruction on core curriculum.
240	245		2. The location of any medical marijuana commercial grower
241	246		shall not be within one thousand (1,000) fee t of any public school
242	247		or private school as measured from the nearest property line of such
243	248		public school or private school to the nearest property line of the
244	249		licensed premises of such medical marijuana commercial gr ower.
245	250		Additionally, the location of th e medical marijuana commercial
246	251		grower shall not adjoin to any public school or private school or be
247	252		located at the same physical address as the public school or private
248	253		school. If a medical marijuana commercial growe r met the
249	254		requirements of this paragrap h at the time of its initial licensu re,
250	255		the medical marijuana commercial grower licensee shal l be permitted
251	256		to continue operating at the licensed premises in the same manner
252	257		and not be subject to nonrenewal or revocat ion due to subsequent
253	258		events or changes in regulations occurring after lice nsure that
254	259		would render the medical marijuana commercial grower in violation of
255	260		this paragraph. If any public school or private school is
256	261		established within one thousand (1,000) fe et of any medical
257	262		marijuana commercial grower after such medical marijuana commercial
258	263		grower has been licensed, or if any public sch ool or private school
259	264		is established adjoining to or at the same physical address as any
260	265		medical marijuana commercial grower after such medical marijuana
261	266		commercial grower has been licensed, the prov isions of this
262	267
263		-	ENGR. S. B. NO. 116 Page 6 1
	268	+	SENATE FLOOR VERSION – SB116 SFLR Page 6
	269	+	(Bold face denotes Committee Amendments) 1
264	270		2
265	271		3
266	272		4
267	273		5
268	274		6
269	275		7
270	276		8
271	277		9
272	278		10
273	279		11
274	280		12
275	281		13
276	282		14
277	283		15
278	284		16
279	285		17
280	286		18
281	287		19
282	288		20
283	289		21
284	290		22
285	291		23
286	292		24
287	293
288	294		paragraph shall not be a deterrent to the renewal of such license or
289	295		warrant revocation of the license. For purposes of this paragraph,
290	296		a property owned, used, or op erated by a public school or by a
291	297		private school that is not used for class room instruction on core
292	298		curriculum, such as an administr ative building, athletic facility,
293	299		ballpark, field, or stadium, shall not constitute a public school or
294	300		private school unles s such property is located on the same campus as
295	301		a building used for classr oom instruction on core c urriculum.
296	302		H. The location of any medical marijuana commercial grower
297	303		shall not be within one thousand (1,000) feet of any place of
298	304		worship as defined in paragraph 50 of Section 427.2 of this ti tle as
299	305		measured from the nearest pro perty line of such place of worship to
300	306		the nearest property line of the licensed premises of such medical
301	307		marijuana commercial gr ower. Additionally, the location of the
302	308		medical marijuana commercial grower shall not adjo in to any place of
303	309		worship or be located at the same physical address as the place of
304	310		worship. If a medical marijuana commercial growe r met the
305	311		requirements of this paragraph at the time of its initial licensure,
306	312		the medical marijuana commercial grower li censee shall be permitted
307	313		to continue operating at the licens ed premises in the same manner
308	314		and not be subject to nonrenewal or revocat ion due to subsequent
309	315		events or changes in regulations occurring after licensure that
310	316		would render the medical marijuana commercial grower in violation of
311	317		this paragraph. If any place of worship is established within one
312	318
313		-	ENGR. S. B. NO. 116 Page 7 1
	319	+	SENATE FLOOR VERSION – SB116 SFLR Page 7
	320	+	(Bold face denotes Committee Amendments) 1
314	321		2
315	322		3
316	323		4
317	324		5
318	325		6
319	326		7
320	327		8
321	328		9
322	329		10
323	330		11
324	331		12
325	332		13
326	333		14
327	334		15
328	335		16
329	336		17
330	337		18
331	338		19
332	339		20
333	340		21
334	341		22
335	342		23
336	343		24
337	344
338	345		thousand (1,000) feet of any medical marijuana commercial grower
339	346		after such medical marijuana commercial grower has been licensed, or
340	347		if any place of worship is established adjoining to or at the same
341	348		physical address as any medical marijuana comme rcial grower after
342	349		such medical marijuana commercial grower has been licensed, the
343	350		provisions of this paragraph shall not be a deterrent to the renewal
344	351		of such license or warrant revocation of the li cense. For purposes
345		-	of this paragraph, a property owned, used, or operated by a
346		-	~~religious organization~~ that is not used on a full-time basis for
347		-	~~worship, such as~~ any administrative building, office space, or
348		-	~~storage facility,~~ shall constitute a place of worship.
	352	+	of this paragraph, a property owned, used, or operated by a place of
	353	+	worship that is not used on a full-time basis for worship, such as
	354	+	any administrative building, office space, or storage facility,
	355	+	shall constitute a place of worship.
349	356		I. Research shall be provided for under this law. A r esearcher
350	357		may apply to the State Departmen t of Health for a special research
351	358		license. The research license shall be granted, provided the
352	359		applicant meets the criteria liste d in the Oklahoma Medical
353	360		Marijuana and Patient Pro tection Act. Research licensees shall be
354	361		required to file monthly consumption repo rts to the State Department
355	362		of Health with amounts of marijuana used for research. Biomedical
356	363		and clinical research which is subject to federal regulations and
357	364		institutional oversight shall not be subject to oversight by the
358	365		State Department of Health.
359	366		SECTION 2. AMENDATORY 63 O.S. 2021, Section 427.2, as
360	367		last amended by Section 1, Chapter 317, O.S.L. 2022 (63 O.S. Supp.
361	368		2022, Section 427.2), is ame nded to read as follows:
362	369
363		-	ENGR. S. B. NO. 116 Page 8 1
	370	+	SENATE FLOOR VERSION – SB116 SFLR Page 8
	371	+	(Bold face denotes Committee Amendments) 1
364	372		2
365	373		3
366	374		4
367	375		5
368	376		6
369	377		7
370	378		8
371	379		9
372	380		10
373	381		11
374	382		12
375	383		13
376	384		14
377	385		15
378	386		16
379	387		17
380	388		18
381	389		19
382	390		20
383	391		21
384	392		22
385	393		23
386	394		24
387	395
388	396		Section 427.2. As used in the Oklahoma Medical Marijuana and
389	397		Patient Protection Act:
390	398		1. “Advertising” means the act of providing consideration for
391	399		the publication, dis semination, solicitation or circulation, of
392	400		visual, oral or written communication to induce directly or
393	401		indirectly any person to patronize a particular medical marijuana
394	402		business, or to purchase particular medical marijuana or a medical
395	403		marijuana product. Advertising includes marketing, but does not
396	404		include packaging and labeling;
397	405		2. “Authority” means the Oklahoma Medical Marijuana Authority;
398	406		3. “Batch number” means a unique numeric or alphanumeric
399	407		identifier assigned prior to testing to allow for inventory tracking
400	408		and traceability;
401	409		4. “Cannabinoid” means any of the chemical compounds that are
402	410		active principles of marijuana;
403	411		5. “Caregiver” means a family member or assistant who regularly
404	412		looks after a medical marijuana license holde r whom a physician
405	413		attests needs assistance;
406	414		6. “Child-resistant” means special packaging that is:
407	415		a. designed or constructed to be significantly difficult
408	416		for children under five (5) years of age to open and
409	417		not difficult for normal adults to use properl y as
410	418		defined by 16 C.F.R. 1700.15 (1995) and 16 C.F .R.
411	419		1700.20 (1995),
412	420
413		-	ENGR. S. B. NO. 116 Page 9 1
	421	+	SENATE FLOOR VERSION – SB116 SFLR Page 9
	422	+	(Bold face denotes Committee Amendments) 1
414	423		2
415	424		3
416	425		4
417	426		5
418	427		6
419	428		7
420	429		8
421	430		9
422	431		10
423	432		11
424	433		12
425	434		13
426	435		14
427	436		15
428	437		16
429	438		17
430	439		18
431	440		19
432	441		20
433	442		21
434	443		22
435	444		23
436	445		24
437	446
438	447		b. opaque so that the outermost packaging does not allow
439	448		the product to be seen without opening the packaging
440	449		material, and
441	450		c. resealable to maintain its child-resistant
442	451		effectiveness for multiple openings for any product
443	452		intended for more than a single use or containing
444	453		multiple servings;
445	454		7. “Clone” means a nonflowering plant cut from a mother plant
446	455		that is capable of developing into a new plant and has shown no
447	456		signs of flowering;
448	457		8. “Commissioner” means the State Commissioner of Health;
449	458		9. “Complete application” means a document prepared in
450	459		accordance with the provisions set forth in the Oklahoma Medical
451	460		Marijuana and Patient Protection Act, rules promulgated pursuant
452	461		thereto, and the forms and instructions provided by the Departmen t
453	462		including any supporting documentation required and the applicable
454	463		license application fee;
455	464		10. “Department” means the State Department of Health;
456	465		11. “Director” means the Executive Director of th e Oklahoma
457	466		Medical Marijuana Authority;
458	467		12. “Dispense” means the selling of medical marijuana or a
459	468		medical marijuana product to a qualified patient or the designated
460	469		caregiver of the patient that is packaged in a suitable container
461	470
462		-	ENGR. S. B. NO. 116 Page 10 1
	471	+	SENATE FLOOR VERSION – SB116 SFLR Page 10
	472	+	(Bold face denotes Committee Amendments) 1
463	473		2
464	474		3
465	475		4
466	476		5
467	477		6
468	478		7
469	479		8
470	480		9
471	481		10
472	482		11
473	483		12
474	484		13
475	485		14
476	486		15
477	487		16
478	488		17
479	489		18
480	490		19
481	491		20
482	492		21
483	493		22
484	494		23
485	495		24
486	496
487	497		appropriately labeled for subsequent administration to or use by a
488	498		qualifying patient;
489	499		13. “Dispensary” means a medical marijuana dispensary, an
490	500		entity that has been licensed by the Department pursuant to the
491	501		Oklahoma Medical Marijuana and Patient Protection Act to purchase
492	502		medical marijuana or medical marijuana products from a lice nsed
493	503		medical marijuana commercial grower or medical marijuana processor,
494	504		sell medical marijuana or medical marijuana products to patients and
495	505		caregivers as defined under the Oklahoma Medical Marijuana and
496	506		Patient Protection Act, or sell or transfer products to another
497	507		dispensary;
498	508		14. “Edible medical marijuana product” means any medical-
499	509		marijuana-infused product for which the intended use is oral
500	510		consumption including, but not limited to, any type of food, drink
501	511		or pill;
502	512		15. “Entity” means an individual, g eneral partnership, limited
503	513		partnership, limited liability company, trust, estate, association,
504	514		corporation, cooperative or any other legal or commercial entity;
505	515		16. “Flower” means the reproductive organs of the marijuana or
506	516		cannabis plant referred to as the bud or parts of the plant that are
507	517		harvested and used to consume in a variety of medical marijuana
508	518		products;
509	519
510		-	ENGR. S. B. NO. 116 Page 11 1
	520	+	SENATE FLOOR VERSION – SB116 SFLR Page 11
	521	+	(Bold face denotes Committee Amendments) 1
511	522		2
512	523		3
513	524		4
514	525		5
515	526		6
516	527		7
517	528		8
518	529		9
519	530		10
520	531		11
521	532		12
522	533		13
523	534		14
524	535		15
525	536		16
526	537		17
527	538		18
528	539		19
529	540		20
530	541		21
531	542		22
532	543		23
533	544		24
534	545
535	546		17. “Flowering” means the reproductive state of the marijuana
536	547		or cannabis plant in which th ere are physical signs of flower or
537	548		budding out of the nodes of the stem;
538	549		18. “Food-based medical marijuana concentrate” means a medical
539	550		marijuana concentrate that was produced by extracting cannabinoids
540	551		from medical marijuana through the use of propylene glycol,
541	552		glycerin, butter, olive oil, coconut oil o r other typical food-safe
542	553		cooking fats;
543	554		19. “Good cause” for purposes of an initial, renewal or
544	555		reinstatement license application, or for purposes of discipline of
545	556		a licensee, means:
546	557		a. the licensee or applicant has violated, does not meet,
547	558		or has failed to comply with any of the terms,
548	559		conditions or provisions of the act, any rules
549	560		promulgated pursuant thereto, or any supplemental
550	561		relevant state or local law, rule or regulation,
551	562		b. the licensee or applica nt has failed to comply with
552	563		any special terms or c onditions that were placed upon
553	564		the license pursuant to an order of the State
554	565		Department of Health, Oklahoma Medical Marijuana
555	566		Authority or the municipality, or
556	567		c. the licensed premises of a medical mariju ana business
557	568		or applicant have been operated in a m anner that
558	569		adversely affects the public health or welfare or the
559	570
560		-	ENGR. S. B. NO. 116 Page 12 1
	571	+	SENATE FLOOR VERSION – SB116 SFLR Page 12
	572	+	(Bold face denotes Committee Amendments) 1
561	573		2
562	574		3
563	575		4
564	576		5
565	577		6
566	578		7
567	579		8
568	580		9
569	581		10
570	582		11
571	583		12
572	584		13
573	585		14
574	586		15
575	587		16
576	588		17
577	589		18
578	590		19
579	591		20
580	592		21
581	593		22
582	594		23
583	595		24
584	596
585	597		safety of the immediate vicinity in which the
586	598		establishment is located;
587	599		20. “Harvest batch” means a specifically identified quantity of
588	600		medical marijuana that is uniform in strain, cultivate d utilizing
589	601		the same cultivation practices, harvested at the same time from the
590	602		same location and cured under uniform conditions;
591	603		21. “Harvested marijuana” means post-flowering medical
592	604		marijuana not including trim, concentrate or waste ;
593	605		22. “Heat- or pressure-based medical marijuan a concentrate”
594	606		means a medical marijuana concentrate that was produced by
595	607		extracting cannabinoids from medical marijuana through the use of
596	608		heat or pressure;
597	609		23. “Immature plant” means a nonflowering marijua na plant that
598	610		has not demonstrated signs of flow ering;
599	611		24. “Inventory tracking system” means the required tracking
600	612		system that accounts for medical marijuana from either the seed or
601	613		immature plant stage until the medical mar ijuana or medical
602	614		marijuana product is sold to a pa tient at a medical marijuana
603	615		dispensary, transferred to a medical marijuana research facility,
604	616		destroyed by a medical marijuana business or used in a research
605	617		project by a medical marijuana research facili ty;
606	618		25. “Licensed patient” or “patient” means a person who has been
607	619		issued a medical marijuana patient license by the State Department
608	620		of Health or Oklahoma Medical Marijuana Authority;
609	621
610		-	ENGR. S. B. NO. 116 Page 13 1
	622	+	SENATE FLOOR VERSION – SB116 SFLR Page 13
	623	+	(Bold face denotes Committee Amendments) 1
611	624		2
612	625		3
613	626		4
614	627		5
615	628		6
616	629		7
617	630		8
618	631		9
619	632		10
620	633		11
621	634		12
622	635		13
623	636		14
624	637		15
625	638		16
626	639		17
627	640		18
628	641		19
629	642		20
630	643		21
631	644		22
632	645		23
633	646		24
634	647
635	648		26. “Licensed premises” means the premises specified in an
636	649		application for a medical marijuana busi ness license, medica l
637	650		marijuana research facilit y license or medical marijuana education
638	651		facility license pursuant to the Oklahoma Medical Marijuana and
639	652		Patient Protection Act that are owned or in possession of the
640	653		licensee and within which the licensee is authorized to cultivate,
641	654		manufacture, distribut e, sell, store, transport, test or research
642	655		medical marijuana or medical marijuana products in accordance with
643	656		the provisions of the Oklahoma Medical Marijuana and Patient
644	657		Protection Act and rules promulgated pursuant thereto;
645	658		27. “Manufacture” means the production, propagation,
646	659		compounding or processing of a medical marijuana product, excluding
647	660		marijuana plants, either directly or indirectly by extraction from
648	661		substances of natural or synthetic origin, or in dependently by means
649	662		of chemical synthesis, or b y a combination of extraction and
650	663		chemical synthesis;
651	664		28. “Marijuana” shall have the same meaning as such term is
652	665		defined in Section 2-101 of this title and shall not includ e any
653	666		plant or material containing delta-8 or delta-10
654	667		tetrahydrocannabinol which is grown, processed or sold pursuant to
655	668		the provisions of the Oklahoma Industrial Hemp Program;
656	669		29. “Material change” means any change that would require a
657	670		substantive revision to the standard operating proc edures of a
658	671
659		-	ENGR. S. B. NO. 116 Page 14 1
	672	+	SENATE FLOOR VERSION – SB116 SFLR Page 14
	673	+	(Bold face denotes Committee Amendments) 1
660	674		2
661	675		3
662	676		4
663	677		5
664	678		6
665	679		7
666	680		8
667	681		9
668	682		10
669	683		11
670	684		12
671	685		13
672	686		14
673	687		15
674	688		16
675	689		17
676	690		18
677	691		19
678	692		20
679	693		21
680	694		22
681	695		23
682	696		24
683	697
684	698		licensee for the cultivation or prod uction of medical marijuana,
685	699		medical marijuana concentrate or medical marijuana products;
686	700		30. “Mature plant” means a harvestable female marijuana plant
687	701		that is flowering;
688	702		31. “Medical marijuana business (MM B)” means a licensed medical
689	703		marijuana dispensary, medical marijuana processor, medical marijuana
690	704		commercial grower, medical marijuana laboratory, medical marijuana
691	705		business operator or a medical marijuana transporter;
692	706		32. “Medical marijuana concentrate ” or “concentrate” means a
693	707		specific subset of medi cal marijuana that was produced by extracting
694	708		cannabinoids from medical marijuana. Categories of medical
695	709		marijuana concentrate include water-based medical marijuana
696	710		concentrate, food-based medical marijuana concentrate, solvent-based
697	711		medical marijuana con centrate, and heat- or pressure-based medical
698	712		marijuana concentrate;
699	713		33. “Medical marijuana commercial grower” or “commercial
700	714		grower” means an entity licensed to cultiv ate, prepare and package
701	715		medical marijuana and transfer or contract for transfer medica l
702	716		marijuana to a medical marijuana dispensary, medical marijuana
703	717		processor, any other medical marijuana commercial grower, medical
704	718		marijuana research facility, medical m arijuana education facility
705	719		and pesticide manufacturers. A commercial grower may sell seeds,
706	720		flower or clones to commercial growers pursuant to the Oklahoma
707	721		Medical Marijuana and Patient Protection Act;
708	722
709		-	ENGR. S. B. NO. 116 Page 15 1
	723	+	SENATE FLOOR VERSION – SB116 SFLR Page 15
	724	+	(Bold face denotes Committee Amendments) 1
710	725		2
711	726		3
712	727		4
713	728		5
714	729		6
715	730		7
716	731		8
717	732		9
718	733		10
719	734		11
720	735		12
721	736		13
722	737		14
723	738		15
724	739		16
725	740		17
726	741		18
727	742		19
728	743		20
729	744		21
730	745		22
731	746		23
732	747		24
733	748
734	749		34. “Medical marijuana education facility ” or “education
735	750		facility” means a person or entit y approved pursuant to the Oklahoma
736	751		Medical Marijuana and Patient Protection Act to operate a facility
737	752		providing training and education to individuals involving the
738	753		cultivation, growing, harvesting, curing, preparing , packaging or
739	754		testing of medical mariju ana, or the production, manufacture,
740	755		extraction, processing, packaging or creation of medical-marijuana-
741	756		infused products or medical marijuana products as described in the
742	757		Oklahoma Medical Marijuana and Patient Protec tion Act;
743	758		35. “Medical-marijuana-infused product” means a product infused
744	759		with medical marijuana including, but not limited to, edible
745	760		products, ointments and tinctures;
746	761		36. “Medical marijuana product” or “product” means a product
747	762		that contains cannabi noids that have been extracted from plant
748	763		material or the resin therefrom by physical or c hemical means and is
749	764		intended for administration to a qualified patient including, but
750	765		not limited to, oils, tinctures, edibles, pills, topical forms,
751	766		gels, creams, vapors, patches, liquids and forms administered by a
752	767		nebulizer, excluding live plant forms which are considered medical
753	768		marijuana;
754	769		37. “Medical marijuana processor” means a person or entity
755	770		licensed pursuant to the Oklahoma Medical Marijuana and Patient
756	771		Protection Act to operate a business includi ng the production,
757	772		manufacture, extraction, proc essing, packaging or creation of
758	773
759		-	ENGR. S. B. NO. 116 Page 16 1
	774	+	SENATE FLOOR VERSION – SB116 SFLR Page 16
	775	+	(Bold face denotes Committee Amendments) 1
760	776		2
761	777		3
762	778		4
763	779		5
764	780		6
765	781		7
766	782		8
767	783		9
768	784		10
769	785		11
770	786		12
771	787		13
772	788		14
773	789		15
774	790		16
775	791		17
776	792		18
777	793		19
778	794		20
779	795		21
780	796		22
781	797		23
782	798		24
783	799
784	800		concentrate, medical-marijuana-infused products or medical marijuana
785	801		products as described in the Oklahoma Medical Marijuana and Pat ient
786	802		Protection Act;
787	803		38. “Medical marijuana research facility” or “research
788	804		facility” means a person or entity approved pursuant to the Oklahoma
789	805		Medical Marijuana and Patient Protection Act to conduct medical
790	806		marijuana research. A medical marijuana rese arch facility is not a
791	807		medical marijuana business;
792	808		39. “Medical marijuana testing laborator y” or “laboratory”
793	809		means a public or private laboratory licensed pursuant to the
794	810		Oklahoma Medical Marijuana and Patient Protection Act, to conduct
795	811		testing and research on medical marijuana and medical marijuana
796	812		products;
797	813		40. “Medical marijuana transporter ” or “transporter” means a
798	814		person or entity that is licensed pursuant to the Oklahoma Medical
799	815		Marijuana and Patient Protection Act. A medical marijuana
800	816		transporter does not include a medical marijuana busine ss that
801	817		transports its own medical mariju ana, medical marijuana concentrate
802	818		or medical marijuana products to a property or facility adjacent to
803	819		or connected to the licensed premises if the property is another
804	820		licensed premises of the same medical marijuana business;
805	821		41. “Medical marijuana waste ” or “waste” means unused, surplus,
806	822		returned or out-of-date marijuana, plant debris of the plant of the
807	823		genus Cannabis including dead plants and all unused plant parts a nd
808	824
809		-	ENGR. S. B. NO. 116 Page 17 1
	825	+	SENATE FLOOR VERSION – SB116 SFLR Page 17
	826	+	(Bold face denotes Committee Amendments) 1
810	827		2
811	828		3
812	829		4
813	830		5
814	831		6
815	832		7
816	833		8
817	834		9
818	835		10
819	836		11
820	837		12
821	838		13
822	839		14
823	840		15
824	841		16
825	842		17
826	843		18
827	844		19
828	845		20
829	846		21
830	847		22
831	848		23
832	849		24
833	850
834	851		roots, except the term shall not include roo ts, stems, stalks and
835	852		fan leaves;
836	853		42. “Medical use” means the acquisition, possession, use,
837	854		delivery, transfer or transportation of medical marijuana, medical
838	855		marijuana products, medical marijuana devices or paraphernalia
839	856		relating to the administration of medical marijuana to treat a
840	857		licensed patient;
841	858		43. “Mother plant” means a marijuana plant that is grown or
842	859		maintained for the purpose of generating clones, and that will not
843	860		be used to produce plant materi al for sale to a medical marijuana
844	861		processor or medical marijuana dispensary;
845	862		44. “Oklahoma physician” or “physician” means a physician
846	863		licensed by and in good standing with the State Board of Medical
847	864		Licensure and Supervision, the State Board of Osteopathic Examiners
848	865		or the Board of Podiatric Medical E xaminers;
849	866		45. “Oklahoma resident” means an individual who can provide
850	867		proof of residency as required by the Oklahoma Medical Marijuana and
851	868		Patient Protection Act;
852	869		46. “Owner” means, except where the context otherwise requires,
853	870		a direct beneficial owner i ncluding, but not limited to, all persons
854	871		or entities as follows:
855	872		a. all shareholders owning an interest of a corporate
856	873		entity and all officers of a corporate entity,
857	874		b. all partners of a general partnership,
858	875
859		-	ENGR. S. B. NO. 116 Page 18 1
	876	+	SENATE FLOOR VERSION – SB116 SFLR Page 18
	877	+	(Bold face denotes Committee Amendments) 1
860	878		2
861	879		3
862	880		4
863	881		5
864	882		6
865	883		7
866	884		8
867	885		9
868	886		10
869	887		11
870	888		12
871	889		13
872	890		14
873	891		15
874	892		16
875	893		17
876	894		18
877	895		19
878	896		20
879	897		21
880	898		22
881	899		23
882	900		24
883	901
884	902		c. all general partners and all limited partn ers that own
885	903		an interest in a limited partnership,
886	904		d. all members that own an interest in a limited
887	905		liability company,
888	906		e. all beneficiaries that hold a beneficial interest in a
889	907		trust and all trustees of a trust,
890	908		f. all persons or entities that own inter est in a joint
891	909		venture,
892	910		g. all persons or entities that own an interest in an
893	911		association,
894	912		h. the owners of any other type of legal entity, and
895	913		i. any other person holding an interest or convertible
896	914		note in any entity which owns, operates or manages a
897	915		licensed facility;
898	916		47. “Package” or “packaging” means any container or wrapper
899	917		that may be used by a medical marijuana business to enclose or
900	918		contain medical marijuana;
901	919		48. “Person” means a natural person, partnership, association,
902	920		business trust, compa ny, corporation, estate, limited liability
903	921		company, trust or any other legal entity or organization, or a
904	922		manager, agent, owner, director, servant, officer or employee
905	923		thereof, except that person does not include any governmental
906	924		organization;
907	925
908		-	ENGR. S. B. NO. 116 Page 19 1
	926	+	SENATE FLOOR VERSION – SB116 SFLR Page 19
	927	+	(Bold face denotes Committee Amendments) 1
909	928		2
910	929		3
911	930		4
912	931		5
913	932		6
914	933		7
915	934		8
916	935		9
917	936		10
918	937		11
919	938		12
920	939		13
921	940		14
922	941		15
923	942		16
924	943		17
925	944		18
926	945		19
927	946		20
928	947		21
929	948		22
930	949		23
931	950		24
932	951
933	952		49. “Pesticide” means any substance or mixture of substances
934	953		intended for preventing, destroying, repelling or mitigating any
935	954		pest or any substance or mixture of substances intended for use as a
936	955		plant regulator, defoliant or desiccant, except t hat the term
937	956		pesticide shall not include any article that is a “new animal drug”
938	957		as designated by the United States Food and Drug Administration;
939	958		50. “Place of worship” means any permanent building, str ucture,
940	959		facility, or office space ow ned, leased, or rented on a full-time
941	960		basis, and used weekly for worship services, activities, or business
942		-	of the ~~religious organization~~, which shall include, but not be
943		-	~~limited to,~~ churches, temples, synagogues, and mosques;
	961	+	of the congregation, which shall include, but not be limited to,
	962	+	churches, temples, synagogues, and mosques;
944	963		51. “Production batch” means:
945	964		a. any amount of medical marijuana concentrate of the
946	965		same category and produced using the same extraction
947	966		methods, standard operating procedures and an
948	967		identical group of harvest batch of medical marijuana,
949	968		or
950	969		b. any amount of medical marijuana product of the same
951	970		exact type, produced using the same ingredients,
952	971		standard operating procedures and the same production
953	972		batch of medical marijuana concentrate;
954	973		51. 52. “Public institution” means any entity established or
955	974		controlled by the federal government, state government, or a local
956	975
957		-	ENGR. S. B. NO. 116 Page 20 1
	976	+	SENATE FLOOR VERSION – SB116 SFLR Page 20
	977	+	(Bold face denotes Committee Amendments) 1
958	978		2
959	979		3
960	980		4
961	981		5
962	982		6
963	983		7
964	984		8
965	985		9
966	986		10
967	987		11
968	988		12
969	989		13
970	990		14
971	991		15
972	992		16
973	993		17
974	994		18
975	995		19
976	996		20
977	997		21
978	998		22
979	999		23
980	1000		24
981	1001
982	1002		government or municipality including, but not limited t o,
983	1003		institutions of higher education or related research institutions;
984	1004		52. 53. “Public money” means any funds or money obtained by the
985	1005		holder from any governmental entity including, but not limited to,
986	1006		research grants;
987	1007		53. 54. “Recommendation” means a document that is signed or
988	1008		electronically submitted by a physician on behalf of a patient for
989	1009		the use of medical marijuana pursuant to the Oklahoma Medical
990	1010		Marijuana and Patient Protection Act;
991	1011		54. 55. “Registered to conduct business” means a person that
992	1012		has provided proof that the business applicant is in good standing
993	1013		with the Secretary of State and Oklahoma Tax Commission;
994	1014		55. 56. “Remediation” means the process by which the medical
995	1015		marijuana flower or trim, which has failed microbial testing, is
996	1016		processed into solvent-based medical marijuana concentrate and
997	1017		retested as required by the Oklahoma Medical Marijuana and Patient
998	1018		Protection Act;
999	1019		56. 57. “Research project” means a discrete scientific endeavor
1000	1020		to answer a research question or a set of research questions rel ated
1001	1021		to medical marijuana and is required fo r a medical marijuana
1002	1022		research license. A research project shall include a description of
1003	1023		a defined protocol, clearly articulated goals, defined methods and
1004	1024		outputs, and a defined start and end date. The descri ption shall
1005	1025		demonstrate that the research pr oject will comply with all
1006	1026
1007		-	ENGR. S. B. NO. 116 Page 21 1
	1027	+	SENATE FLOOR VERSION – SB116 SFLR Page 21
	1028	+	(Bold face denotes Committee Amendments) 1
1008	1029		2
1009	1030		3
1010	1031		4
1011	1032		5
1012	1033		6
1013	1034		7
1014	1035		8
1015	1036		9
1016	1037		10
1017	1038		11
1018	1039		12
1019	1040		13
1020	1041		14
1021	1042		15
1022	1043		16
1023	1044		17
1024	1045		18
1025	1046		19
1026	1047		20
1027	1048		21
1028	1049		22
1029	1050		23
1030	1051		24
1031	1052
1032	1053		requirements in the Oklahoma Medical Marijuana and Patient
1033	1054		Protection Act and rules promulgated pursuant thereto. All research
1034	1055		and development conducted by a medical marijuana research facility
1035	1056		shall be conducted in furtherance of an approved research project;
1036	1057		57. 58. “Revocation” means the final decision by the Department
1037	1058		that any license issued pursuant to the Oklahoma Medical Marijuana
1038	1059		and Patient Protection Act is rescinded because the individual or
1039	1060		entity does not comply with the applicable requirements set forth in
1040	1061		the Oklahoma Medical Marijuana and Patient Protection Act or rules
1041	1062		promulgated pursuant thereto;
1042	1063		58. 59. “School” means a public or private preschool, a public
1043	1064		or private elementary or secondary school, or a technology center
1044	1065		school which is primarily used for classroom instruction. A
1045	1066		homeschool, daycare or child-care facility shall not be considered a
1046	1067		“school” as used in the Oklahoma Medical Marijuana and Patient
1047	1068		Protection Act;
1048	1069		59. 60. “Shipping container” means a hard-sided container with
1049	1070		a lid or other enclosure that can be secured in place. A shipping
1050	1071		container is used solel y for the transport of medical marijuana,
1051	1072		medical marijuana concentrate, or medical marijuana products between
1052	1073		medical marijuana businesses, a medical marijuana research facility,
1053	1074		or a medical marijuana education facility;
1054	1075		60. 61. “Solvent-based medical marijuana concentrate” means a
1055	1076		medical marijuana concentrate that was produced by extracting
1056	1077
1057		-	ENGR. S. B. NO. 116 Page 22 1
	1078	+	SENATE FLOOR VERSION – SB116 SFLR Page 22
	1079	+	(Bold face denotes Committee Amendments) 1
1058	1080		2
1059	1081		3
1060	1082		4
1061	1083		5
1062	1084		6
1063	1085		7
1064	1086		8
1065	1087		9
1066	1088		10
1067	1089		11
1068	1090		12
1069	1091		13
1070	1092		14
1071	1093		15
1072	1094		16
1073	1095		17
1074	1096		18
1075	1097		19
1076	1098		20
1077	1099		21
1078	1100		22
1079	1101		23
1080	1102		24
1081	1103
1082	1104		cannabinoids from medical marijuana through the use of a solvent
1083	1105		approved by the Department;
1084	1106		61. 62. “State Question” means Oklahoma State Question No. 788,
1085	1107		Initiative Petition No. 412, approved by a majority vote of the
1086	1108		citizens of Oklahoma on June 26, 2018;
1087	1109		62. 63. “Strain” means the classification of marijuana or
1088	1110		cannabis plants in either pure sati va, indica, afghanica, ruderalis
1089	1111		or hybrid varieties;
1090	1112		63. 64. “THC” means tetrahydrocannabinol, which is the primary
1091	1113		psychotropic cannabinoid in marijuana formed by dec arboxylation of
1092	1114		naturally tetrahydrocannabinolic acid, which generally occurs by
1093	1115		exposure to heat;
1094	1116		64. 65. “Test batch” means with regard to usable marijuana, a
1095	1117		homogenous, identified quantity of usable marijuana by strain, no
1096	1118		greater than ten (10) pounds, t hat is harvested during a seven-day
1097	1119		period from a specified cultivation area, and with regard to oils,
1098	1120		vapors and waxes derived from usable marijuana, means an identifie d
1099	1121		quantity that is uniform, that is intended to meet specifications
1100	1122		for identity, strength and composition, and that is manufactured,
1101	1123		packaged and labeled during a specified time period according to a
1102	1124		single manufacturing, packaging and labeling protocol;
1103	1125		65. 66. “Transporter agent” means a person who transports
1104	1126		medical marijuana or medical marijuana products for a licensed
1105	1127
1106		-	ENGR. S. B. NO. 116 Page 23 1
	1128	+	SENATE FLOOR VERSION – SB116 SFLR Page 23
	1129	+	(Bold face denotes Committee Amendments) 1
1107	1130		2
1108	1131		3
1109	1132		4
1110	1133		5
1111	1134		6
1112	1135		7
1113	1136		8
1114	1137		9
1115	1138		10
1116	1139		11
1117	1140		12
1118	1141		13
1119	1142		14
1120	1143		15
1121	1144		16
1122	1145		17
1123	1146		18
1124	1147		19
1125	1148		20
1126	1149		21
1127	1150		22
1128	1151		23
1129	1152		24
1130	1153
1131	1154		transporter and holds a transporter agent license pursuant to the
1132	1155		Oklahoma Medical Marijuana and Patient Protection Act;
1133	1156		66. 67. “Universal symbol” means the image established by the
1134	1157		State Department of Health or Oklahoma Medical Marijuana Authority
1135	1158		and made available to licensees through its website indicating that
1136	1159		the medical marijuana or the medical marijuana product contains THC;
1137	1160		67. 68. “Usable marijuana” means the dried leaves, flowers,
1138	1161		oils, vapors, waxes and other portions of the mariju ana plant and
1139	1162		any mixture or preparation thereof, exc luding seeds, roots, stems,
1140	1163		stalks and fan leaves; and
1141	1164		68. 69. “Water-based medical marijuana concentrate ” means a
1142	1165		concentrate that was produced by extracting cannabinoids from
1143	1166		medical marijuana through the use of only water, ice or dry ice.
1144	1167		SECTION 3. This act shall become effect ive November 1, 2023.
1145		-	Passed the Senate the 21st day of March, 2023.
1146		-
1147		-
1148		-
1149		-	Presiding Officer of the Senate
1150		-
1151		-
1152		-	Passed the House of Representatives the ____ day of __________,
1153		-	2023.
1154		-
1155		-
1156		-
1157		-	Presiding Officer of the House
1158		-	of Representatives
1159		-
	1168	+	COMMITTEE REPORT BY: COMMITTEE ON BUSINESS AND COMMERCE
	1169	+	February 8, 2023 - DO PASS